ketanserin has been researched along with Consciousness, Loss of in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Petrenko, AB | 1 |
| Yamakura, T | 1 |
| Kohno, T | 1 |
| Sakimura, K | 1 |
| Baba, H | 1 |
1 other study available for ketanserin and Consciousness, Loss of
| Article | Year |
|---|---|
Increased brain monoaminergic tone after the NMDA receptor GluN2A subunit gene knockout is responsible for resistance to the hypnotic effect of nitrous oxide.
Topics: Anesthetics; Animals; Biogenic Monoamines; Brain; Droperidol; Drug Resistance; Gene Knockout Techniq | 2013 |